‘Effectiveness of various sulbactam-based combination antibiotic therapy in the management of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in a tertiary care Health centre’
Indian Journal of Medical Microbiology · 2024
DOI: 10.1016/j.ijmmb.2024.100737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical Microbiology, 2024. Verfasst von Monika Chaudhary und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic addre…. Hauptthemen laut MEDLINE: Sulbactam, Acinetobacter baumannii, Anti-Bacterial Agents, Pneumonia, Ventilator-Associated. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
OBJECTIVE: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a common cause of ventilator-associated pneumonia (VAP). Some in vitro data favour various combination antibiotic therapy. However, there is a need for more in vivo studies for the management of VAP caused by CRAB. This retrospective study was done to evaluate the effectiveness of various combination antibiotic therapy including sulbactam on outcomes of VAP caused by CRAB. METHODS: Adult patients (age ≥18 years) diagnosed with VAP caused by CRAB were included. Patients with polymicrobial infections were excluded from the study. Patients with CRAB associated VAP who were given sulbactam based antibiotic combinations were observed for outcomes. The primary outcome was 28-day mortality after diagnosis of VAP caused by CRAB. Reduction in serum HsCRP (High sensitivity C-reactive protein) during treatment and requirement of inotropes were the secondary outcomes. Outcomes were compared between various sulbactam based antibiotic combination therapies. RESULTS: A total of 103 patients were included. A total of 44 (42.7 %) patients received sulbactam and minocycline or sulbactam and polymyxin B dual antibiotic combination, and 59 (57.3 %) patients received sulbactam, polymyxin B and minocycline triple antibiotic combination. The percentage difference in 28 days mortality was 27.51 % (95 % CI 8.03 %-44.06 %; p = 0.005) in dual vs triple sulbactam based antibiotic combination therapy. The percentage difference in requirement of inotropes during therapy and HsCRP reduction after 7 days of therapy was 23.65 % (95 % CI 6.43 %-38.3 %; p = 0.007) and 25.1 % (95%CI 10.1 %-38.2 %; p < 0.001) respectively when compared between dual vs triple sulbactam based antibiotic combination therapy. CONCLUSION: Treatment with sulbactam, polymyxin B and minocycline combination antibiotic therapy was associated with significantly lower 28-day mortality. Moreover, the lower requirement of inotropes during treatment and a significant reduction in HsCRP level favours this combination antibiotic therapy in VAP caused by CRAB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic address: munu301086@gmail.com.
- Division of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic address: deepak1007sharma@gmail.com.
- Division of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic address: dsmims14@gmail.com.
- Division of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic address: midha.naresh@gmail.com.
- Division of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic address: bohragk@aiimsjodhpur.edu.in.
- Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Electronic address: vibhor_tak@yahoo.com.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Chaudhary, M., Kumar, D., Meena, D. S., Midha, N. K., Bohra, G. K., Tak, V., Samantaray, S., Kaur, N., Neetha, T. R., Mohammed, S., Sharma, A., Kothari, N., Bhatia, P. K., & Garg, M. K. (2024). ‘Effectiveness of various sulbactam-based combination antibiotic therapy in the management of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in a tertiary care Health centre’. Indian Journal of Medical Microbiology. https://doi.org/10.1016/j.ijmmb.2024.100737
Vancouver
Chaudhary M, Kumar D, Meena DS, Midha NK, Bohra GK, Tak V, et al. ‘Effectiveness of various sulbactam-based combination antibiotic therapy in the management of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in a tertiary care Health centre’. Indian Journal of Medical Microbiology. 2024. doi:10.1016/j.ijmmb.2024.100737
BibTeX
@article{Chaudhary2024,
author = {Chaudhary, Monika and Kumar, Deepak and Meena, Durga Shankar and Midha, Naresh Kumar and Bohra, Gopal Krishana and Tak, Vibhor and Samantaray, Subhashree and Kaur, Navneet and Neetha, T R and Mohammed, Sadik and Sharma, Ankur and Kothari, Nikhil and Bhatia, Pradeep Kumar and Garg, M K},
title = {‘Effectiveness of various sulbactam-based combination antibiotic therapy in the management of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in a tertiary care Health centre’},
journal = {Indian Journal of Medical Microbiology},
year = {2024},
doi = {10.1016/j.ijmmb.2024.100737}
}
EUVIMED